Skip to main content
OpenTrials

Clinical trial condition

Oestrogen Receptor Positive Advanced Breast Cancer

Explore clinical trials studying Oestrogen Receptor Positive Advanced Breast Cancer. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Oestrogen Receptor Positive Advanced Breast Cancer trial results

Completed

An Open Label Study of Postmenopausal Women With Oestrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer Treated With Everolimus (RAD001) With Exemestane, With Exploratory Epigenetic Marker Analysis

NCT01743560

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +4 more
Locations
  • Novartis Investigative Site Epping, Essex, United Kingdom
  • Novartis Investigative Site Inverness, Invernesshire, United Kingdom
  • Novartis Investigative Site Ipswich, Suffolk, United Kingdom
  • Novartis Investigative Site Sutton, Surrey, United Kingdom
View Trial Details

Related conditions